IH vs PM

iHuman Inc. presents a classic deep-value paradox: it possesses a stable Piotroski F-Score of 6/9 and an exceptionally clean balance sheet, yet it is plagued by severe growth decay. While the stock trades at a significant discount to its Graham Number ($4.08) and book value (P/B 0.61), the negative YoY revenue (-18.10%) and earnings (-33.30%) growth suggest a value trap. The current price of $1.74 is slightly below the growth-based intrinsic value of $1.82, but the bearish technical trend and weak insider sentiment offset the valuation appeal.

Philip Morris International (PM) presents a compelling investment case supported by strong profitability, consistent earnings growth, and a resilient dividend profile. Despite near-term price weakness over the past six months (-7.3%), the stock has delivered exceptional long-term returns (+153.1% over 5Y), underpinned by robust YoY EPS growth of 17.3% and a track record of beating earnings estimates in 22 of the last 25 quarters. The company’s high operating margin (40.75%) and gross margin (66.92%) reflect pricing power and cost discipline in a defensive sector, while its forward P/E of 21.59 appears justified given growth and stability. Analysts concur with a unanimous buy rating and a $185.75 target price, implying ~19.5% upside, reinforcing confidence in continued outperformance.